Chemoembolization, Therapeutic
"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.
Descriptor ID |
D016461
|
MeSH Number(s) |
E02.520.360.150 E02.926.500.150
|
Concept/Terms |
Chemoembolization, Therapeutic- Chemoembolization, Therapeutic
- Therapeutic Chemoembolization
- Chemoembolizations, Therapeutic
- Therapeutic Chemoembolizations
|
Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".
Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".
This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in this website by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1996 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 2 | 0 | 2 |
2000 | 2 | 0 | 2 |
2001 | 1 | 0 | 1 |
2003 | 3 | 0 | 3 |
2004 | 2 | 0 | 2 |
2005 | 3 | 1 | 4 |
2006 | 1 | 4 | 5 |
2007 | 1 | 0 | 1 |
2008 | 4 | 1 | 5 |
2009 | 0 | 1 | 1 |
2010 | 1 | 4 | 5 |
2011 | 2 | 1 | 3 |
2012 | 1 | 1 | 2 |
2013 | 3 | 2 | 5 |
2014 | 1 | 2 | 3 |
2015 | 2 | 2 | 4 |
2016 | 2 | 0 | 2 |
2017 | 3 | 4 | 7 |
2018 | 4 | 1 | 5 |
2019 | 4 | 2 | 6 |
2020 | 0 | 3 | 3 |
2021 | 1 | 2 | 3 |
2022 | 3 | 0 | 3 |
2023 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.
-
Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. J Gastrointest Surg. 2023 09; 27(9):1867-1875.
-
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2023 Apr; 46(4):449-459.
-
A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis. Eur Radiol Exp. 2023 01 30; 7(1):4.
-
Multimodality annotated hepatocellular carcinoma data set including pre-?and post-TACE with imaging segmentation. Sci Data. 2023 01 18; 10(1):33.
-
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. J Immunother Cancer. 2022 06; 10(6).
-
Survival and recurrence rates of hepatocellular carcinoma after treatment of chronic hepatitis C using direct acting antivirals. Eur J Gastroenterol Hepatol. 2022 02 01; 34(2):227-234.
-
Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma. Mol Oncol. 2022 05; 16(10):1986-1999.
-
The Impact of the Use of C-Arm Cone-Beam CT During Chemoembolization for Hepatocellular Carcinoma. Curr Med Imaging. 2022; 18(4):372-380.
-
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Deliv. 2021 Dec; 28(1):240-251.
-
Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma. Nanomedicine. 2022 01; 39:102465.